Logo image of ELYS

ELYS GAME TECHNOLOGY CORP (ELYS) Stock Fundamental Analysis

NASDAQ:ELYS - Nasdaq - US2907341026 - Common Stock - Currency: USD

0.41  -0.1 (-19.21%)

After market: 0.1396 -0.27 (-65.95%)

Fundamental Rating

2

ELYS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 131 industry peers in the Hotels, Restaurants & Leisure industry. ELYS has a bad profitability rating. Also its financial health evaluation is rather negative. ELYS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ELYS had negative earnings in the past year.
In the past year ELYS has reported a negative cash flow from operations.
In the past 5 years ELYS always reported negative net income.
In the past 5 years ELYS reported 4 times negative operating cash flow.
ELYS Yearly Net Income VS EBIT VS OCF VS FCFELYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -5M -10M -15M

1.2 Ratios

ELYS has a worse Return On Assets (-78.33%) than 96.40% of its industry peers.
Looking at the Return On Equity, with a value of -296.29%, ELYS is doing worse than 71.94% of the companies in the same industry.
Industry RankSector Rank
ROA -78.33%
ROE -296.29%
ROIC N/A
ROA(3y)-49%
ROA(5y)-39.27%
ROE(3y)-129.85%
ROE(5y)-106.28%
ROIC(3y)N/A
ROIC(5y)N/A
ELYS Yearly ROA, ROE, ROICELYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150 -200 -250

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ELYS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ELYS Yearly Profit, Operating, Gross MarginsELYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 -20 -30 -40

More info and screens

1

2. Health

2.1 Basic Checks

ELYS does not have a ROIC to compare to the WACC, probably because it is not profitable.
ELYS has more shares outstanding than it did 1 year ago.
ELYS has a worse debt/assets ratio than last year.
ELYS Yearly Shares OutstandingELYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
ELYS Yearly Total Debt VS Total AssetsELYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -4.19, we must say that ELYS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -4.19, ELYS is not doing good in the industry: 94.24% of the companies in the same industry are doing better.
ELYS has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.38, ELYS is doing good in the industry, outperforming 70.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z -4.19
ROIC/WACCN/A
WACC8.28%
ELYS Yearly LT Debt VS Equity VS FCFELYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M -5M 10M 15M 20M

2.3 Liquidity

ELYS has a Current Ratio of 0.52. This is a bad value and indicates that ELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.52, ELYS is not doing good in the industry: 76.98% of the companies in the same industry are doing better.
A Quick Ratio of 0.52 indicates that ELYS may have some problems paying its short term obligations.
ELYS has a worse Quick ratio (0.52) than 72.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
ELYS Yearly Current Assets VS Current LiabilitesELYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

ELYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.94%, which is quite impressive.
The Revenue has been growing slightly by 3.74% in the past year.
Measured over the past years, ELYS shows a quite strong growth in Revenue. The Revenue has been growing by 13.29% on average per year.
EPS 1Y (TTM)21.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
Revenue 1Y (TTM)3.74%
Revenue growth 3Y6.25%
Revenue growth 5Y13.29%
Sales Q2Q%9.56%

3.2 Future

The Earnings Per Share is expected to grow by 36.71% on average over the next years. This is a very strong growth
ELYS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.32% yearly.
EPS Next Y52.64%
EPS Next 2Y36.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.52%
Revenue Next 2Y18.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ELYS Yearly Revenue VS EstimatesELYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ELYS Yearly EPS VS EstimatesELYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ELYS. In the last year negative earnings were reported.
Also next year ELYS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ELYS Price Earnings VS Forward Price EarningsELYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ELYS Per share dataELYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as ELYS's earnings are expected to grow with 36.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.71%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ELYS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELYS GAME TECHNOLOGY CORP

NASDAQ:ELYS (10/16/2023, 8:24:30 PM)

After market: 0.1396 -0.27 (-65.95%)

0.41

-0.1 (-19.21%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-14 2023-08-14/amc
Earnings (Next)11-13 2023-11-13/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners33.84%
Ins Owner Change0%
Market Cap15.91M
Analysts82.5
Price Target2.04 (397.56%)
Short Float %0.03%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.71%
Min EPS beat(2)-28.68%
Max EPS beat(2)19.26%
EPS beat(4)1
Avg EPS beat(4)-57.34%
Min EPS beat(4)-136.93%
Max EPS beat(4)19.26%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.34%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)7.34%
Revenue beat(4)1
Avg Revenue beat(4)-5.38%
Min Revenue beat(4)-20.79%
Max Revenue beat(4)7.34%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-20.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 2.66
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.6
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.13
BVpS0.15
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.33%
ROE -296.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-49%
ROA(5y)-39.27%
ROE(3y)-129.85%
ROE(5y)-106.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.94
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 230.04%
Cap/Sales 8.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -4.19
F-Score3
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)79.67%
Cap/Depr(5y)188.21%
Cap/Sales(3y)3.05%
Cap/Sales(5y)4.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
EPS Next Y52.64%
EPS Next 2Y36.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.74%
Revenue growth 3Y6.25%
Revenue growth 5Y13.29%
Sales Q2Q%9.56%
Revenue Next Year10.52%
Revenue Next 2Y18.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-25.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-128.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.93%
OCF growth 3YN/A
OCF growth 5YN/A